LY3832479
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LY3832479, covering 2021-12-06 to 2022-03-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness [Phase 2, Phase 3]